{"@context":"https:\/\/schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Phase 2 Randomized Control Trial of Evexomostat (SDX-7320) in Combination with Eribulin for Patients with Metastatic Triple-Negative Breast Cancer and Metabolic Dysfunction: The ARETHA Study","item":"https:\/\/www.regionalcancercare.org\/trials\/phase-2-randomized-control-trial-of-evexomostat-sdx-7320-in-combination-with-eribulin-for-patients-with-metastatic-triple-negative-breast-cancer-and-metabolic-dysfunction-the-aretha-study\/#breadcrumbitem"}]}